REGISTROS MAIS RECENTES

Preprint

Os dados são atualizados diariamente a partir das seguintes fontes: 

medrxiv.org

biorxiv.org

arxiv.org

www.ssrn.com/index.cfm/en/

https://preprints.scielo.org/index.php/scielo

Busque por termos

Selecione ao lado o filtro desejado:

Últimos registros

Abaixo os últimos 30 registros encontrados em nossa base de dados.

Digite um termo acima para filtrar sua busca na tabela abaixo.

Repositório Título Autores Data URL
arxivReal-time Face Mask Detection in Video DataYuchen Ding ;Zichen Li ;David Yastremsky 2021-05-05
medrxivDoes the Data Tell the True Story? A Modelling Study of Early COVID-19 Pandemic Suppression and Mitigation Strategies in GhanaNana Kena Frempong, ...2021-05-05
arxivModelling the Second Covid-19 Wave in MumbaiSandeep Juneja ;Daksh Mittal 2021-05-05
medrxivdPQL: a lossless distributed algorithm for generalized linear mixed model with application to privacy-preserving hospital profilingChongliang Luo, ...2021-05-05
medrxivInvestigating the relationship between serum ACE 2 level and COVID-19 patients' prognosis: a cross-sectional studyParsa Mohammadi, ...2021-05-05
arxivThe Kids Are / Not / Sort of All RightCaroline Pitt The Information School, University of Washington (The Information School, University of Washington);Ari Hock College of Education, University of Washington (College of Education, University of Washington);Leila Zelnick Department of Medicine, University of Washington (Department of Medicine, University of Washington);Katie Davis The Information School, University of Washington (The Information School, University of Washington)2021-05-05
medrxivA SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test PerformanceLori Bourassa, ...2021-05-05
medrxivCOVID-19 infection and hospitalization according to the burden of chronic noncommunicable diseases in BrazilFabiana Ribeiro Ferraz, ...2021-05-05
medrxivRoles of generation-interval distributions in shaping relative epidemic strength, speed, and control of new SARS-CoV-2 variantsSang Woo Park, ...2021-05-05
medrxivOptimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled studySaye H Khoo, ...2021-05-05
biorxivSARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapyAlexander M Horspool, ...2021-05-05
medrxivPopulation behavioural dynamics can mediate the persistence of emerging infectious diseasesKathyrn R Fair, ...2021-05-05
biorxivSARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccinationMarkus Hoffmann, ...2021-05-05
biorxivSequencing SARS-CoV-2 in a malaria research laboratory in Mali, West Africa: the road to sequencing the first SARS-CoV-2 genome in MaliAntoine Dara, ...2021-05-05
medrxivA Call For Better Methodological Quality Of Reviews On Using Artificial Intelligence For COVID-19 Detection In Medical Imaging - An Umbrella Systematic ReviewPaweł Jemioło, ...2021-05-05
medrxivPreventing COVID-19 Outbreaks Through Surveillance Testing in Healthcare Facilities - A Modelling StudyTim Litwin, ...2021-05-05
medrxivImplementation of SARS-CoV2 Screening in K-12 Schools using In-School Pooled Molecular Testing and Deconvolution by Rapid Antigen TestNira R Pollock, ...2021-05-05
medrxivSmart Testing with Vaccination: A Bandit Algorithm for Active Sampling for Managing COVID-19Yingfei Wang, ...2021-05-05
medrxivPopulation Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the USZixin Hu, ...2021-05-05
medrxivROCCA study protocol and interim analysis on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino: an observational study using active surveillanceMarco Montalti, ...2021-05-05
medrxivMale-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State AnalysisJay J Xu, ...2021-05-05
biorxivPrior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variantKwe Claude Yinda, ...2021-05-05
medrxivCesarean section prevalence at a baby-friendly hospital in southern Brazil: current context in the face of COVID-19Manoela de Azevedo Bicho, ...2021-05-05
medrxivProlonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisAnne-Gaelle Goubet, ...2021-05-05
medrxivInfants are more susceptible to COVID-19 than childrenChar Leung2021-05-05
medrxivLENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALZelalem Temesgen, ...2021-05-05
medrxivPrevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysishuilei zhao, ...2021-05-05
biorxivUncovering cryptic pockets in the SARS-CoV-2 spike glycoproteinLorena Zuzic, ...2021-05-05
medrxivWithin-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient: a source of immune escape variantsSebastian Weigang, ...2021-05-05
biorxivProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung InflammationKameswari S Konduri, ...2021-05-05
Acompanhe conosco outras fontes importantes sobre covid-19 do Brasil
https://covid.saude.gov.br/

Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Diariamente, o Ministério da Saúde, por meio da Secretaria de Vigilância em Saúde (SVS/MS) divulga dados consolidados sobre o COVID-19. Saiba mais sobre o painel.

https://bigdata-covid19.icict.fiocruz.br/

Este projeto utiliza recursos computacionais e cientistas de dados da Plataforma de Ciência de Dados aplicada à Saúde do Laboratório de Informação em Saúde do Icict da Fiocruz (PCDaS), hospedada no Laboratório Nacional de Computação Científica (LNCC).

Campus Sede:

Av. Brasil, 4365 – Manguinhos, Rio de Janeiro – CEP: 21040-900 – Tel: (0xx21) 2598-4242

Este portal é regido pela Política de Acesso Aberto ao Conhecimento, que busca garantir à sociedade o acesso gratuito, público e aberto ao conteúdo integral de toda obra intelectual produzida pela Fiocruz.

© COPYRIGHT / Todos os direitos reservados ao Laboratório de Informação Científica e Tecnológica em Saúde – LICTS / FIOCRUZ